ROSEN, A LEADING LAW FIRM, Encourages Endava plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – DAVA |
Globe Newswire |
09/21 |
09:04 |
Bumbana Nyami Announces the Launch of Its Game |
Globe Newswire |
09/21 |
08:45 |
ROSEN, LEADING INVESTOR COUNSEL, Encourages DXC Technology Company Investors to Secure Counsel Before Important October 1 Deadline in Securities Class Action – DXC |
Globe Newswire |
09/21 |
08:37 |
Yeeha! Games Partners with SOMSOC GALLERY to Bridge Web2 and Web3 through Designer Toy Art |
Globe Newswire |
09/21 |
08:33 |
ROSEN, A RANKED AND LEADING FIRM, Encourages Sprinklr, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CXM |
Globe Newswire |
09/21 |
08:24 |
EXTR INVESTOR UPDATE: Extreme Networks, Inc. Investors that Lost Money are Notified to Contact BFA Law before October 15 Class Action Deadline (Nasdaq:EXTR) |
Globe Newswire |
09/21 |
07:18 |
FIVE INVESTOR UPDATE: Five Below, Inc. Investors that Lost Money are Notified to Contact BFA Law before September 30 Class Action Deadline (Nasdaq:FIVE) |
Globe Newswire |
09/21 |
07:18 |
SMCI INVESTOR UPDATE: Super Micro Computer Investors that Lost Money are Notified to Contact BFA Law before October 29 Class Action Deadline (Nasdaq:SMCI) |
Globe Newswire |
09/21 |
07:16 |
FORD INVESTOR UPDATE: Ford Motor Company Investors that Lost Money are Notified to Contact BFA Law before October 7 Class Action Deadline (NYSE:F) |
Globe Newswire |
09/21 |
07:16 |
Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed with Schizophrenia |
Globe Newswire |
09/21 |
04:15 |
New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY® (risperidone) Extended-Release Injectable Suspension from Perseris® (RBP-7000) |
Globe Newswire |
09/21 |
04:10 |
ACADIA HEALTHCARE COMPANY, INC. ANNOUNCEMENT: If You Have Suffered Losses in Acadia Healthcare Company, Inc. (NASDAQ: ACHC), You Are Encouraged to Contact The Rosen Law Firm About Your Rights |
Globe Newswire |
09/20 |
21:17 |
ROSEN, A LEADING LAW FIRM, Encourages WEBTOON Entertainment Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WBTN |
Globe Newswire |
09/20 |
21:07 |
American Airlines ALERT: Bragar Eagel & Squire, P.C. is Investigating American Airlines Group Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm |
Globe Newswire |
09/20 |
21:00 |
Bragar Eagel & Squire, P.C. Is Investigating Aviat and Flux and Encourages Investors to Contact the Firm |
Globe Newswire |
09/20 |
21:00 |
Bragar Eagel & Squire, P.C. Is Investigating Dyne, Napco, and Franklin and Encourages Investors to Contact the Firm |
Globe Newswire |
09/20 |
21:00 |
Bragar Eagel & Squire, P.C. Is Investigating MaxLinear, Customers Bancorp, Globus, and Metagenomi and Encourages Investors to Contact the Firm |
Globe Newswire |
09/20 |
21:00 |
Bragar Eagel & Squire, P.C. Is Investigating LPL Financial, Bumble, Cardlytics, and European Wax and Encourages Investors to Contact the Firm |
Globe Newswire |
09/20 |
21:00 |
Everett Dorey - Unanimous Defense Victory in Los Angeles “Toxic Mold” Jury Trial |
Globe Newswire |
09/20 |
20:48 |
ROSEN, A LEADING LAW FIRM, Encourages Super Micro Computer, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SMCI |
Globe Newswire |
09/20 |
20:00 |
FLUX POWER HOLDINGS, INC. ANNOUNCEMENT: If You Have Suffered Losses in Flux Power Holdings, Inc. (NASDAQ: FLUX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights |
Globe Newswire |
09/20 |
19:45 |
ROSEN, A LEADING LAW FIRM, Encourages CAE Inc. Investors to Inquire About Securities Class Action Investigation – CAE |
Globe Newswire |
09/20 |
19:13 |
Bunker Hill Announces Election to Issue Shares in Satisfaction of Debenture Interest Payment Obligations |
Globe Newswire |
09/20 |
19:00 |
Press Release: Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant |
Globe Newswire |
09/20 |
18:36 |
ROSEN, A LEADING LAW FIRM, Encourages XPEL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – XPEL |
Globe Newswire |
09/20 |
18:20 |